Stock screener

AURA

Conviction 42HealthcareScan · Thu, Sep 24, 2026
Bullish harami

Aura Biosciences, Inc. (AURA) closed at $6.17 (+2.41%) on Sep 24, 2026. Its latest daily candle is a bullish harami. Price is below its 50-day and below its 200-day moving average. RSI(14) 31, RS Rating 32, -30.7% from its 52-week high, +16.3% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

AURA$6.17+2.41%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 1.07M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
Aura Biosciences, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.aurabiosciences.com ↗
Price6.17
Change+2.41%
Gap+0.00%
Rel volume2.81×
Avg volume919.72K
Avg $ vol6.2M
SMA 206.97
SMA 507.25
SMA 2006.65
Price vs 50-14.91%
Price vs 200-7.23%
MA stackmixed
50/200 cross—
Supertrenddown · 7.13
RSI (14)31
MACD hist-0.11
MACD cross—
Stoch %K / %D13 / 10
ADX (14)23
+DI / −DI9 / 27
RSI divergence—
MACD divergence—
ATR %5.74%
ADR %4.86%
52w high8.90
52w low4.97
From 52w high-30.73%
Above 52w low+24.04%
New 52w highNo
SqueezeOff
Bollinger width27.67%
%B0.08
Donchian pos11.56%
Donchian high7.81
Donchian low5.95
AVWAP (52w high)7.31
vs AVWAP high-15.68%
AVWAP (52w low)7.12
vs AVWAP low-13.42%
OBV trendDown
Chaikin MF (20)-0.26
Today vs 20d2.81×
Avg vol (14d)1.07M
Avg vol (20d)919.72K
Avg $ vol (20d)6.2M
Market cap639.34M
RS Rating32 / 99
RS 3m (vs SPY)-14.62%
RS 6m (vs SPY)-21.68%
RS line new highNo
Trend template3/8
Technical rank22.9
1 week-6.45%
1 month-21.16%
3 months-10.13%
6 months-4.86%
1 year-0.88%
YTD+16.32%
P/E-6.02
P/B2.03
P/S—
P/FCF-7.50
EPS-1.76
Div yield—
ROE-33.68%
ROA-30.50%
Debt/Eq—
Current16.82
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-22.17%
Price target20.50
Target upside232.52%
Analyst ratingBuy
Institutional101.47%
Ent. value571.5M
Revenue—
Net income-45.64M
Gross profit—
Free cash flow-85.19M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out103.39M
Employees113
ListedFri, Oct 29, 2021
Free float44.24M
Float %68.9%
Short interest6.2M
Days to cover6.4d
Short volume86.2%
Squeeze score88 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.48 vs −$0.41
Last surprise-17.1% miss
Setup gradeD
Conviction42 / 100
Pattern quality—
Tech rank22.9 / 100
Group rank59 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBullish harami

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in AURA

All disclosures →
No recent disclosed trades by Congress in AURA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in AURA

InsiderSideShares
Abu-Absi Susan
Chief Operating Officer · Common Stock · 2026-09-01
Grant134.51K
Abu-Absi Susan
Chief Operating Officer · Stock Option (Right to Buy) · 2026-09-01
Grant265.49K
Hopkins Janet Jill
Chief Medical Officer · Common Stock · 2026-09-01
Grant58.85K
Hopkins Janet Jill
Chief Medical Officer · Stock Option (Right to Buy) · 2026-09-01
Grant116.15K
Elazzouzi Amy
SVP, Finance & PAO · Common Stock · 2026-09-01
Grant23.54K
Elazzouzi Amy
SVP, Finance & PAO · Stock Option (Right to Buy) · 2026-09-01
Grant46.46K
Kratz Erica
Chief Reg. & Quality Officer · Common Stock · 2026-09-01
Grant100.89K
Kratz Erica
Chief Reg. & Quality Officer · Stock Option (Right to Buy) · 2026-09-01
Grant199.12K
Person Julie
Chief People Officer · Common Stock · 2026-09-01
Grant107.61K
Person Julie
Chief People Officer · Stock Option (Right to Buy) · 2026-09-01
Grant212.39K

SEC filings

EDGAR filings in AURA · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.